Journal of Comprehensive Pediatrics

Published by: Kowsar

The Efficacy of Nebulized Soluble Mannitol and Comparison with 5% Hypertonic Saline on Pulmonary Function of Children with Cystic Fibrosis

Saeed Sadr 1 , Masood Kiani 2 , * , Mohammad Rezaei 3 , Ghamartaj Khanbabaee 1 , Seyed Ahmad Tabatabaee 1 and Amirhossein Hosseini ORCID 4
Authors Information
1 Department of Pediatric Pulmonology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, IR Iran
3 Shahid Rajaei Heart Center, Tehran University of Medical Sciences, Tehran, Iran
4 Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Comprehensive Pediatrics: August 31, 2019, 10 (3); e85616
  • Published Online: June 10, 2019
  • Article Type: Research Article
  • Received: October 21, 2018
  • Revised: May 15, 2019
  • Accepted: May 20, 2019
  • DOI: 10.5812/compreped.85616

To Cite: Sadr S, Kiani M, Rezaei M, Khanbabaee G, Tabatabaee S A, et al. The Efficacy of Nebulized Soluble Mannitol and Comparison with 5% Hypertonic Saline on Pulmonary Function of Children with Cystic Fibrosis, J Compr Ped. 2019 ; 10(3):e85616. doi: 10.5812/compreped.85616.

Copyright © 2019, Journal of Comprehensive Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Verkman AS, Song Y, Thiagarajah JR. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am J Physiol Cell Physiol. 2003;284(1):C2-15. doi: 10.1152/ajpcell.00417.2002. [PubMed: 12475759].
  • 2. Puchelle E, Bajolet O, Abely M. Airway mucus in cystic fibrosis. Paediatr Respir Rev. 2002;3(2):115-9. [PubMed: 12297057].
  • 3. Donaldson SH, Boucher RC. Sodium channels and cystic fibrosis. Chest. 2007;132(5):1631-6. doi: 10.1378/chest.07-0288. [PubMed: 17998363].
  • 4. Aitken ML, Bellon G, De Boeck K, Flume PA, Fox HG, Geller DE, et al. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study. Am J Respir Crit Care Med. 2012;185(6):645-52. doi: 10.1164/rccm.201109-1666OC. [PubMed: 22198974].
  • 5. Ratjen FA. Cystic fibrosis: pathogenesis and future treatment strategies. Respir Care. 2009;54(5):595-605. [PubMed: 19393104].
  • 6. Davies JC, Alton EW, Bush A. Cystic fibrosis. BMJ. 2007;335(7632):1255-9. doi: 10.1136/bmj.39391.713229.AD. [PubMed: 18079549]. [PubMed Central: PMC2137053].
  • 7. Goralski JL, Boucher RC, Button B. Osmolytes and ion transport modulators: New strategies for airway surface rehydration. Curr Opin Pharmacol. 2010;10(3):294-9. doi: 10.1016/j.coph.2010.04.003. [PubMed: 20439165].
  • 8. Daviskas E, Anderson SD, Eberl S, Young IH. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction. Respir Med. 2010;104(11):1645-53. doi: 10.1016/j.rmed.2010.05.019. [PubMed: 20576419].
  • 9. Daviskas E, Anderson SD, Jaques A, Charlton B. Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis. Chest. 2010;137(4):861-8. doi: 10.1378/chest.09-2017. [PubMed: 19880909].
  • 10. Chan JG, Kwok PC, Young PM, Chan HK, Traini D. Mannitol delivery by vibrating mesh nebulisation for enhancing mucociliary clearance. J Pharm Sci. 2011;100(7):2693-702. doi: 10.1002/jps.22494. [PubMed: 21283985].
  • 11. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006;354(3):229-40. doi: 10.1056/NEJMoa043900. [PubMed: 16421364].
  • 12. Daviskas E, Anderson SD, Brannan JD, Chan HK, Eberl S, Bautovich G. Inhalation of dry-powder mannitol increases mucociliary clearance. Eur Respir J. 1997;10(11):2449-54. [PubMed: 9426077].
  • 13. Bilton D, Robinson P, Cooper P, Gallagher CG, Kolbe J, Fox H, et al. Inhaled dry powder mannitol in cystic fibrosis: An efficacy and safety study. Eur Respir J. 2011;38(5):1071-80. doi: 10.1183/09031936.00187510. [PubMed: 21478216].
  • 14. Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B, et al. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: A phase 3 comparison study with hypertonic (4.5%) saline. Respir Res. 2005;6:144. doi: 10.1186/1465-9921-6-144. [PubMed: 16336673]. [PubMed Central: PMC1326200].
  • 15. Jaques A, Daviskas E, Turton JA, McKay K, Cooper P, Stirling RG, et al. Inhaled mannitol improves lung function in cystic fibrosis. Chest. 2008;133(6):1388-96. doi: 10.1378/chest.07-2294. [PubMed: 18339790].
  • 16. Teper A, Jaques A, Charlton B. Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial. J Cyst Fibros. 2011;10(1):1-8. doi: 10.1016/j.jcf.2010.08.020. [PubMed: 20888307].
  • 17. Nolan SJ, Thornton J, Murray CS, Dwyer T. Inhaled mannitol for cystic fibrosis. Cochrane Database Syst Rev. 2015;(10). CD008649. doi: 10.1002/14651858.CD008649.pub2. [PubMed: 26451533].
  • 18. Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006;354(3):241-50. doi: 10.1056/NEJMoa043891. [PubMed: 16421365].
  • 19. Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax. 1997;52(10):900-3. doi: 10.1136/thx.52.10.900. [PubMed: 9404379]. [PubMed Central: PMC1758438].
  • 20. Gupta S, Ahmed F, Lodha R, Gupta YK, Kabra SK. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: A double-blind randomized, controlled trial. J Trop Pediatr. 2012;58(5):375-81. doi: 10.1093/tropej/fms004. [PubMed: 22374985].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments